methyl 5-aminolevulinate has been researched along with Lichen Sclerosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Arisi, M; Calzavara-Pinton, I; Calzavara-Pinton, P; Fabbrocini, G; Megna, M; Monfrecola, G; Rossi, M; Rovati, C | 1 |
| Cannizzaro, MV; Chimenti, S; Criscuolo, AA; Messinese, S; Piccione, E; Saraceno, R; Schipani, C | 1 |
| Lacour, JP; Ortonne, JP; Passeron, T | 1 |
1 review(s) available for methyl 5-aminolevulinate and Lichen Sclerosis
| Article | Year |
|---|---|
A Critical Reappraisal of Off-Label Use of Photodynamic Therapy for the Treatment of Non-Neoplastic Skin Conditions.
Topics: Acne Vulgaris; Aminolevulinic Acid; Cosmetic Techniques; Humans; Lichen Sclerosus et Atrophicus; Off-Label Use; Photochemotherapy; Photosensitizing Agents; Rejuvenation; Skin Diseases; Skin Diseases, Infectious | 2021 |
2 other study(ies) available for methyl 5-aminolevulinate and Lichen Sclerosis
| Article | Year |
|---|---|
New therapeutic approaches in the treatment of anogenital lichen sclerosus: does photodynamic therapy represent a novel option?
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Aminolevulinic Acid; Anus Diseases; Calcineurin Inhibitors; Dermatologic Agents; Female; Glycine max; Humans; Lichen Sclerosus et Atrophicus; Male; Middle Aged; Persea; Photochemotherapy; Photosensitizing Agents; Plant Extracts; Prospective Studies; Quality of Life; Severity of Illness Index; Treatment Outcome | 2017 |
Comparative treatment of extragenital lichen sclerosus with methylaminolevulinic Acid pulsed dye laser-mediated photodynamic therapy or pulsed dye laser alone.
Topics: Abdominal Wall; Aminolevulinic Acid; Female; Follow-Up Studies; Humans; Laser Therapy; Lasers, Dye; Lichen Sclerosus et Atrophicus; Middle Aged; Photochemotherapy; Photosensitizing Agents | 2009 |